Results 311 to 320 of about 4,217,284 (379)

Candida Parapsilosis: a Rare Culprit of Shunt Infection in an Adult. [PDF]

open access: yesCase Rep Surg
Ikizoglu E   +5 more
europepmc   +1 more source

Correction: Diagnostic yield of standardized screening for deep venous thrombosis in patients with acute cerebral ischemia and cardiac right-to-left shunt. [PDF]

open access: yesNeurol Res Pract
Michael KM   +10 more
europepmc   +1 more source

Venesection and resolution of erythrocytosis are not associated with reduced thrombotic risk in secondary and idiopathic polycythaemia: Results from a dual centre, 5‐year retrospective study

open access: yes
British Journal of Haematology, EarlyView.
B. D. Maybury   +25 more
wiley   +1 more source

Profunda femoris-popliteal shunt. Medical approach.

open access: yesMinnesota medicine, 1966
H H, Farley   +2 more
openaire   +1 more source

Ventriculoperitoneal Shunt Complications

Challenging Cases in Pediatric Hospital Medicine, 2020
The evaluation of children with suspected ventriculoperitoneal shunt (VPS) malfunction has evolved into a diagnostic dilemma. This patient population is vulnerable not only to the medical risks of hydrocephalus and surgical complications but also to ...

semanticscholar   +1 more source

Transjugular Intrahepatic Portosystemic Shunt: A Medical Perspective

Digestive Diseases, 1995
The transjugular intrahepatic portosystemic shunt (TIPS) is an exciting new addition to the therapeutic armamentarium against portal hypertension. It is currently indicated for salvage of patients with active variceal hemorrhage despite sclerotherapy or where sclerotherapy is not feasible.
Mitchell L. Shiffman, Arun J. Sanyal
openaire   +3 more sources

Treatment of Cerebrospinal Fluid Shunt Infections with Medical Therapy Alone

Neurosurgery, 1982
Abstract Eight of 48 patients with shunt infections were treated with antibiotic therapy only. Seven of the 8 were cured and remained infection-free for at least 1 year. Six of the 7 patients had developed infection within 2 weeks of shunt insertion or revision.
K Shapiro, J Glaser, S Mates
openaire   +3 more sources

Do P‐glycoprotein Medications Alter the Risk of Ventriculoperitoneal Shunt in Adults with Hydrocephalus?

The Journal of Clinical Pharmacology, 2023
AbstractHydrocephalus is a disorder caused by excess fluid accumulation in the brain and results in brain damage with consequent cognitive and physical problems. This condition has no cure; the only treatment is brain surgery. Experimental data indicate that P‐glycoprotein (P‐gp) plays a crucial role in the pathogenesis of hydrocephalus due to its ...
Jason R. Grullon   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy